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Translocations involving the T cell receptor alpha/delta 
(TCRα/δ) chain locus, which bring oncogenes in the proximity 
of the TCRα enhancer, are one of the hallmark features of 
human T cell malignancies from ataxia telangiectasia (AT) and 
non-AT patients. These lesions are frequently generated by the 
fusion of DNA breaks at the TCRα/δ locus to a disperse region 
centromeric of the immunoglobulin heavy chain (IgH) locus. 
Aberrant VDJ joining accounts for TCRα/δ associated DNA 
cleavage, but the molecular mechanism that leads to genera-
tion of the “oncogene partner” DNA break is unclear. Here 
we show that in ATM deficient primary mouse T cells, IgH/
TCRα/δ fusions arise at a remarkably similar frequency as in 
human AT lymphocytes. Recombinase-activating gene (RAG) is 
responsible for both TCRα/δ as well as IgH associated breaks on 
chromosome 12 (Chr12), which are subject to varying degrees 
of chromosomal degradation. We suggest a new model for how 
oncogenic translocations can arise from two non-concerted 
physiological DSBs.
Introduction
One of the most frequent cytogenetic abnormalities found in 
prolymphocytic leukemia, adult T cell leukemia and in leukemias 
from AT patients are translocations and inversions between the 
TCRα locus (14q11) and a disperse region near band 14q32.1 The 
breakpoints at 14q32 span a region of 450 kb that is centromeric 
of the telomere-proximal IgH locus and frequently includes the 
TCL1 oncogene.1,2 In primary lymphocytes from normal indi-
viduals, non-clonal t(14;14)(q11;q32) translocations appear at a 
frequency of 0.002%.3 AT patients exhibit a 250-fold increase 
in the probability of developing leukemia or lymphoma, and the 
frequency of non-clonal t(14;14)(q11;q32) translocations is also 
increased 250-fold (0.5%) in primary AT lymphocytes.4
Atm-/- mice provide a model for studying lymphoid tumor 
development in AT patients. Atm-/- mice are predisposed to thymic 
lymphomas,5 all of which harbor chromosome 14 (Chr14) rear-
rangements involving the TCRα locus.6 TCRα/δ translocations 
are also common in primary Atm-/- T cells,6 and these rearrange-
ments are dependent on expression of the RAG endonuclease 
which introduces DSBs at Ig and TCR loci during V(D)J recombi-
nation.7 Mouse Chr12 is homologous to human chromosome 14, 
and is a translocation partner for TCRα/δ in approximately 50% 
of Atm-/- thymic lymphomas.6 Analogous to human T cell tumors, 
the breakpoints on chromosome 12 in Atm-/- mouse lymphomas 
map to a disperse region centromeric of the IgH locus, and there is 
a frequent loss of the IgH locus on the translocated chromosome.6 
Since there is a wide dispersion of breakpoints in a region outside 
of the IgH locus for both human t(14:14)(q11;q32) and mouse 
T(12;14) translocations, this suggests that unlike the TCRα/δ 
locus, the “oncogenic” partner might not be targeted by RAG.
Recently, it was shown that ATM functions in two comple-
mentary ways to maintain chromosomal integrity during V(D)
J recombination.7-11 In the absence of ATM, the ability to repair 
antigen receptor coding intermediates at Ig and TCR loci is signifi-
cantly compromised.9,11 In addition to its role in DNA double 
strand break (DSB) repair, ATM prevents the transmission of DNA 
double strand breaks (DSBs) to daughter cells,7 potentially by acti-
vation of a p53 dependent apoptotic checkpoint.12 Impairment 
in both of these repair and checkpoint functions likely accounts 
for the high level of antigen receptor-associated DSBs in mature 
lymphocytes, some of which are generated earlier in development 
as a result of failed V(D)J recombination.7,12 Although broken 
antigen receptor loci with telomere-free ends persist through 
several rounds of cell division, they are characterized by varying 
degrees of chromosomal erosion.7 Prior to loss of essential genetic 
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material, terminally deleted chromosomes have the  potential to 
fuse with chromosomes broken in subsequent generations, as 
suggested by the increase in IgH associated translocations after 
irradiation.7 Here we show that RAG endonuclease dependent 
IgH breaks in ATM-/- T cells can persist with varying degree of 
chromosomal loss and fuse at a high frequency to RAG-dependent 
TCRα/δ breaks. RAG dependent DSBs on both chromosomes 
might also be the source of the highly selected translocation in 
prolymphocytic leukemia and adult T cell leukemias.
Results and Discussion
Recombination between immunoglobulin Dh and Jh segments 
occurs at a high frequency not only in developing B cells but also 
in early T lineage progenitors in the thymus.13-17 Nevertheless, 
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Figure 1. For figure legend, see page 2410.
Etiology of TCRα/δ-associated translocations
2410 Cell Cycle 2009; Vol. 8 Issue 15
of diverse sizes indicative of Dh-Jh rearrangements (Fig. 1A). 
Among these 126 clones, 59 had two diverse fragments indicating 
that in these cells both IgH alleles in the αβ T cells had undergone 
rearrangements. Thus, at least 49% of ATM deficient T cells have 
undergone Dh-Jh rearrangements on one or both alleles.
Since failed V(D)J recombination intermediates are transmitted 
to downstream progenitors in the absence of ATM,7 we speculated 
that aberrant Ig Dh-Jh rearrangements generated in immature 
Atm-/- T cells might accumulate as IgH-associated breaks in mature 
T cells. To test this, we analyzed metaphase spreads from day two 
Atm-/- lymph node T cells by fluorescence in situ hybridization 
(FISH) with probes specific for chromosome 12 (Chr12), IgH 
Cα, and telomere repeats.18,19 Amongst 199 metaphases analyzed 
from two independent Atm-/- mice, seven of them (3.5%) showed 
IgH associated chromosome breaks evidenced by loss of telomeric 
sequences (Fig. 1B). In two of the aberrant metaphases, there 
was also a failure to hybridize with the IgH Cα probe, which is 
centromeric of the VDJ cluster. Cytogenetic analysis using DAPI-
banding revealed that both of these breaks localized near band F1, 
which is the same Chr12 region observed in some of the t(12;14) 
translocations in Atm-/- tumors.6 In contrast to Atm-/- cells, the IgH 
locus was intact in all of the T cells derived from WT littermate 
controls (n = 200 metaphases) (Fig. 1B).
To determine whether Ig heavy chain specific chromosome 
breaks in mature T cells are products of V(D)J recombination, we 
performed the IgH FISH assay on metaphase spreads from Atm-/-
Rag2-/-TCRAND T cells.7 TCRAND is a transgenic T cell receptor 
that reconstitutes T cell development and generates mature clono-
typic T cells in the absence of RAG.20 In contrast to lymph node 
T cells from Atm-/- mice, no IgH chromosome breaks were found 
in T cells from Atm-/-Rag2-/-TCRAND mice (n = 70 metaphases) 
(Fig. 1B). Thus, IgH-associated DNA damage in mature Atm-/- T 
cells is dependent on RAG mediated cleavage. To control for the 
possibility that IgH breaks in ATM deficient cells are generated 
by RAG re-expression in mature T cells, we treated WT lymph 
node T cells with KU55933 (ATMi), a small molecule inhibitor 
of ATM kinase activity. This treatment increased the total number 
of aberrant metaphases to levels similar to those found in Atm-/- T 
cells (data not shown). However, unlike WT B cells stimulated to 
undergo class switch recombination,7 treatment of T cells with 
ATMi did not produce IgH-specific DNA damage (n = 106 meta-
productive assembly of Ig genes is restricted to B cells, since Ig 
variable Vh segments are not recombined in T cells. To determine 
the frequency of Dh-Jh rearrangements in ATM deficient cells, we 
performed Southern blot analysis on mature T cell hybridomas 
generated from mature αβ T cells from two Atm-/- mice. All of 
the 257 hybridomas analyzed gave a 6.6 kb band indicative of an 
un-rearranged IgH allele, as would be expected given that both IgH 
alleles of the BW5147 fusion partner are un-rearranged. However, 
126 of the hybridoma clones had one or two hybridizing fragments 
Figure 1. IgH rearrangements, breaks and translocations in ATM deficient T cells. (A) Southern blot analysis of Ig Dh-Jh rearrangements in mature αβ 
T cell hybridomas. Rearrangements were identified by hybridizing EcoRI digested genomic DNA with a probe downstream of Jh4, as indicated on the 
schematic. Germline band at 6.6 kb is indicated. (B) Percentage of metaphases with abnormalities specifically associated with the IgH locus. Metaphases 
from Atm+/+ (WT), Atm-/-, Atm-/-RAG2-/-TCRAND and WT T cells treated with the ATM inhibitor (ATMi) were prepared 48 hours after lymph node T 
cell stimulation and analyzed using the IgH/telomere FISH assay as described.18 At least two independent mice were analyzed for each genotype. (C) 
Examples of translocations between Chr12 and Chr14. Metaphases were hybridized with a Chr12 painting probe (green), a Chr14 painting probe 
(red) and a IgH Cα BAC probe (yellow), and counterstained with DAPI (blue) (top) or a Chr12 painting probe (green), a TCRα probe (red) and a IgH 
Cα BAC probe (yellow) (lower). Among 2012 metaphase spreads analyzed by FISH, 0.14% showed Chr12/Chr14 fusions in which the breakpoints 
on Chr12 were centromeric of Cα (left), and in 0.54% of cases, Cα was precisely at the breakpoint (right). M-FISH analysis estimated Chr12/Chr14 
fusions at a somewhat higher frequency (1.11%, see Table 1). FISH-labeled metaphases were imaged using a Zeiss AxioImager M1 wide-field upright 
epifluorescence microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY), equipped with a motorized scanning stage and monochrome progres-
sive scan video CCD camera (JAI America Inc., Woburn, MA), controlled by Metafer image acquisition and metaphase pattern recognition software 
(Metasystems Group Inc., Watertown, MA). Automated identification of metaphases used the pattern recognition algorithm in the MSearch module of 
the Metafer software (version 4.0). For M-FISH, metaphases were hybridized with the 21x mouse 21-color probe cocktail from Metasystems GmbH 
(Watertown, MA), and analyzed using Isis software.
Table 1  Frequencies of translocations involving  
chromosomes 12 and 14 in ATM-/- T cells  
(n = 450 metaphases scored, from three  
experiments)
Type Translocation % Frequency
T(14;12) or T(12;14)  1.11%










T(14;13) or T(13;14)  3.56%








T(12;x) indicates partners for chromosome 12 translocations, excluding chromosome 14. T(14;x) indi-
cates partners for chromosome 14 translocations, excluding chromosome 12.
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The frequency of the Chr14-Chr12 translocation in primary 
ATM-/- T cells produced by RAG mediated cleavage of both 
chromosomes (6.9 x 10-3) is 2–3 orders of magnitude higher 
than c-myc/IgH translocations induced in primary Atm-/- B cells 
(2 x 10-6) by AID dependent DSBs,18 or by I-SCE1 or RAG 
endonuclease translocation reporters21,22 (3 x 10-5). To determine 
whether Chr12 and Chr14 were indeed favored partners for 
translocation, we used multi-color FISH (M-FISH) to karyotype 
metaphases from 3 independent ATM-/- mice (Table 1). Among 
450 metaphases examined, 61 (13.5%) exhibited translocations. 
Among these translocations, 25 (41%) involved Chr14 and 19 
(31%) involved Chr12; therefore these two chromosomes are 
involved in 78.5% of all translocations. Fusions between Chr12 
and Chr14 were highly favored, as 17% of all Chr14 transloca-
tions involved Chr12, and 26% of all Chr12 partners were Chr14. 
Strikingly, in addition to Chr12/Chr14 translocations, another 
favored fusion partner for Chr14 was Chr13 (3.5% of all meta-
phases). However, unlike the Chr12/Chr14 translocation, which 
occurs in 50% of ATM-/- thymic lymphomas,6 translocations 
involving Chr13 were not found amongst 8 thymic lymphomas 
previously analyzed by spectral karyotyping.6 Although we do not 
currently know the etiology of the Chr13 translocation, our data 
provide evidence that some high frequency translocation events in 
primary cells are highly selected for while others are not.
Abnormal V(D)J joining likely accounts for the TCRα/δ 
translocations found in primary lymphocytes and lymphomas 
from ATM-deficient patients and mice. In human T cell tumors, 
phases) (Fig. 1B). Thus, IgH associated breaks, characterized by 
varying degrees of chromosomal loss, are not caused by de novo 
cleavage in mature ATM deficient cells, but more likely, they are 
produced earlier as a result of failed Dh-Jh recombination during 
thymocyte development. Nevertheless, these RAG-dependent 
chromosome breaks initiated in the thymus persist in the periph-
eral T cell compartment.
RAG-dependent IgH breaks in ATM deficient T cells occur at 
a frequency of 3.5% (Fig. 1B), while RAG-dependent TCRα/δ 
breaks are found in 5.8% of metaphases (n = 1212 metaphases 
analyzed, not shown). Given the high level of unresolved/persis-
tent breaks, we wished to determine the frequency of translocation 
between these loci. Metaphase spreads from Atm-/- T cells lymph 
node cells were identified using an automated image acquisition 
system and image analysis software (for details see Materials and 
Methods). Among 2012 metaphase spreads analyzed by FISH 
with probes specific for Chr12, Chr14 and IgH Cα, 14 of them 
(0.68%) harbored t(12;14) translocations or dic(12;14) dicen-
tric chromosomes (Fig. 1C). This is remarkably similar to the 
incidence of t(14;14)(q11;q32) translocations (0.5%) or inv(14) 
inversions (0.65%) found in human AT lymphocytes.4 In three of 
14 translocations, the breakpoints on Chr12 were located centro-
meric of Cα (Fig. 1C), consistent with chromosomal degradation. 
Using probes specific for TCRα, Chr12 and IgH Cα, we detected 
fusions in which TCRα/IgHCα were at the breakpoint and 
fusions between TCRα and Chr12, in which Cα hybridization 
was lost (Fig. 1C).
Figure 2. Model for translocations in ATM deficient T cells. Immunoglobulin Ig Dh-Jh recombination associated DSB in immature (DN/DP CD4-/-CD8-/-/
CD4+CD8+) thymoctyes may persist until they translocate to the TCRα/δ locus during failed Vα-Jα or Vδ-DδJδ recombination. Oncogenes localized 
centromeric of IgH might be brought into the vicinity of the TCRα enhancer (or other element) if the unprotected telemore-free Chr12 end is subject to 
degradation.
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the TCRα joining (J) region is frequently fused with a region 10 
Mb centromeric of IgH that includes the TCL1 oncogene locus. 
The molecular mechanism that leads to generation of DNA 
breaks downstream of IgH has remained unclear. Although our 
data do not rule out that stochastic processes or fragile DNA 
segments can contribute to DNA breakage, we suggest that even 
breakpoints that are centromeric to the IgH locus might arise 
from failed V(D)J recombination. In Atm-/- thymocytes, unre-
solved IgH breaks generated by RAG mediated cleavage persist 
throughout T cell development and are subject to exo-nuclease 
digestion.7,8 These IgH associated breaks with varying degrees of 
chromosome loss may fuse to the TCRα/δ locus during Vα-Jα 
rearrangement. If chromosomal degradation occurs juxtaposing 
an oncogene on the eroded chromosome to the TCRα enhancer 
(or other transcription promoting element), deregulation of the 
transforming gene can ensue, resulting in clonal T cell expan-
sion (Fig. 2). In this way, chromosomal breakpoints centromeric 
of the IgH locus may be selected for during lymphomagenesis. 
IgH-TCRα/δ fusions occur at a remarkably high frequency in 
ATM deficient lymphocytes, but they might also occasionally 
arise in normal cells because of the high level of DNA damage 
at these loci and the imperfect nature of the DNA damage 
 checkpoint.3,23
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